Investors Heavily Search Novavax, Inc. (NVAX): Here is What You Need to Know

Novavax (NVAX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Zacks Investment Research • Oct 21, 2026

Novavax (NVAX) Stock Declines While Market Improves: Some Information for Investors

Novavax (NVAX) concluded the recent trading session at $10.82, signifying a -3.91% move from its prior day's close.

Zacks Investment Research • Oct 19, 2026

Novavax shareholder Shah Capital to step back from activist role

Shah Capital, one of Novavax's top shareholders, said on Friday ​it no longer seeks to influence ‌control of the vaccine maker after restructuring into a family office.

Reuters • Oct 16, 2026

Novavax Plunges 12% as Selloff Hits Vaccine Makers; Moderna Tumbles 10%, Pfizer Holds Steady

Vaccine stocks are under heavy pressure, and the smallest name in the group is taking the heaviest losses. Novavax (NASDAQ:NVAX) stock is down 12% to $11.23 in afternoon trading, leading the slide among vaccine developers.

24/7 Wall Street • Oct 16, 2026

Moderna and Novavax Stocks Slump as Biotech's Rally Takes a Breather

Moderna and Revolution Medicines have upcoming catalysts that could help sustain their gains, even as biotech stocks retreat.

Barrons • Oct 16, 2026

Novavax (NVAX) Increases Despite Market Slip: Here's What You Need to Know

In the most recent trading session, Novavax (NVAX) closed at $12.82, indicating a +1.26% shift from the previous trading day.

Zacks Investment Research • Oct 13, 2026

Vaccine Stocks Rally on Reports of U.S.-led Push for Cancer Vaccines

MRNA, BNTX and NVAX shares rally after reports of a planned NIH-backed initiative to accelerate personalized cancer vaccines and expand research funding.

Zacks Investment Research • Oct 12, 2026

Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know

Novavax (NVAX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Zacks Investment Research • Oct 9, 2026

Novavax Soars 16%, Moderna Surges 11%, Merck Climbs 3% as Biotech Rallies

Vaccine and biotechnology names are leading a sharp sector rally, and a small protein-vaccine developer is posting the biggest gain of the group. Novavax (NASDAQ:NVAX) shares recently changed hands at $12.77, up 16%.

24/7 Wall Street • Oct 9, 2026

Novavax Stock Falls Back: What's Going On?

Novavax Inc. (NASDAQ:NVAX) shares are pulling back Tuesday after a more than 20% surge Monday. Vaccine stocks rallied after a suspected pneumonic plague case in Russia.

Benzinga • Oct 6, 2026